Oil prices rise on talk of Russia sanctions; bouncing off recent lows
Investing.com -- U.S. Trade Representative Jamieson Greer indicated openness to "creative solutions" regarding pharmaceutical trade between the United States and European Union, according to Irish Trade Minister Simon Harris on Wednesday.
Harris, who met with Greer last month, told reporters that the U.S. official acknowledged the interdependent nature of the pharmaceutical industry between the U.S., EU, and Ireland specifically.
"He made it clear that he was open to creative solutions when it comes to pharma and I think that’s an important recognition that actually pharma between the U.S. and the EU, the U.S. and Ireland, is much more interdependent than perhaps people were led to believe in certain quarters at the start of this process," Harris said.
The Irish minister noted a positive intensity in the ongoing trade discussions between the EU and U.S. While a 10% tariff appears to be the baseline in agreements the U.S. has reached so far, Harris stated that Brussels will pursue zero-for-zero tariffs across as many sectors as possible.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.